Carboranyl thymidine analogues for neutron capture therapy

Area of Science:

• Oncology
• Radiochemistry
• Medicinal Chemistry

Background:

• Neutron capture therapy (NCT) is a cancer treatment combining radiation and chemotherapy.
• Developing tumor-selective agents is crucial for effective NCT.
• Thymidine analogues are a promising class of NCT agents.

Purpose of the Study:

• To discuss the chemical, structural, and biological properties of 3-carboranyl thymidine analogues (3CTAs).
• To highlight 3CTAs as novel agents for improved cancer therapy via NCT.

Main Methods:

• Synthesis and characterization of thymidine analogues.
• Boron-containing carborane cluster incorporation at the N3 position.
• Evaluation of chemical, structural, and biological properties.

Main Results:

• 3CTAs demonstrate potential as effective NCT agents.
• The N3 substitution with carborane clusters influences their properties.
• Detailed chemical, structural, and biological data are presented.

Conclusions:

• 3CTAs represent a significant advancement in NCT agent development.
• Their unique properties offer enhanced tumor selectivity and therapeutic efficacy.
• Further research into 3CTAs is warranted for clinical applications in cancer treatment.